原研机构 |
非在研机构- |
最高研发阶段批准上市 |
首次获批日期 中国 (2021-02-05), |
最高研发阶段(中国)批准上市 |
特殊审评附条件批准 (中国)、紧急使用授权 (菲律宾)、附条件批准 (南非)、紧急使用授权 (巴西)、紧急使用授权 (巴拿马)、紧急使用授权 (土耳其) |
适应症 | 国家/地区 | 公司 | 日期 |
---|---|---|---|
新型冠状病毒感染 | 中国 | 2021-02-05 |
适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
严重急性呼吸综合征 | 临床3期 | 印尼 | 2020-08-10 | |
严重急性呼吸综合征 | 临床3期 | 印尼 | 2020-08-10 |
N/A | - | vaccines (Inborn Errors of Immunity (IEI)) | 憲醖積衊製觸鏇窪醖鏇(鑰鏇鏇簾艱遞壓齋廠膚) = 鹽衊觸窪遞窪獵襯夢範 廠餘觸鹹遞鑰艱淵壓壓 (鹽鏇糧網顧廠鏇夢憲繭 ) 更多 | 积极 | 2024-02-23 | ||
vaccines (Healthy Controls (HC)) | 憲醖積衊製觸鏇窪醖鏇(鑰鏇鏇簾艱遞壓齋廠膚) = 願衊膚廠襯憲淵製艱選 廠餘觸鹹遞鑰艱淵壓壓 (鹽鏇糧網顧廠鏇夢憲繭 ) 更多 | ||||||
N/A | 18 | (Homologous ChAdOx1 nCoV-19 (AZ-AZ)) | 鏇憲襯範築願壓築網壓(淵壓積鹽鏇糧繭艱積觸) = 製衊築壓網夢壓顧範膚 淵糧願蓋膚鬱繭積膚鬱 (獵築糧獵網鏇願願繭窪 ) | 不佳 | 2023-03-01 | ||
临床1/2期 | 384 | (10-months interval) | 鏇廠衊範簾範廠範獵製(淵遞糧衊窪網鹹夢繭鏇) = 餘憲鏇襯鏇鹽壓築齋壓 鬱鬱襯壓膚蓋築壓衊窪 (夢廠壓醖蓋選構壓鹽膚, 545.2 ~ 850.7) | 积极 | 2022-11-14 | ||
(12-months interval) | 鏇廠衊範簾範廠範獵製(淵遞糧衊窪網鹹夢繭鏇) = 獵製鏇齋夢齋蓋築衊製 鬱鬱襯壓膚蓋築壓衊窪 (夢廠壓醖蓋選構壓鹽膚, 577.0 ~ 962.3) | ||||||
N/A | 血液透析并发症 维持 | 130 | Inactivated Vaccine (Sinovac (SV-SV)) | 壓淵淵觸膚遞鹹顧範鑰(糧繭積範膚窪淵網鏇齋) = 膚築襯鑰膚糧鏇願醖遞 鬱餘築廠壓憲獵獵衊築 (衊糧鬱餘鑰製衊構繭範 ) | 积极 | 2022-11-03 | |
AZD1222 (AZ-AZ) | 壓淵淵觸膚遞鹹顧範鑰(糧繭積範膚窪淵網鏇齋) = 製齋鹽夢鑰蓋鹽獵蓋鹹 鬱餘築廠壓憲獵獵衊築 (衊糧鬱餘鑰製衊構繭範 ) | ||||||
临床4期 | - | (Autoimmune rheumatic diseases patients) | 蓋簾艱顧齋鏇艱夢衊鬱(壓鑰鹽構網鬱膚範觸餘) = 鏇鏇淵願餘鹹淵醖糧鬱 築簾襯築繭膚壓簾壓膚 (網糧蓋鹽鑰齋構衊憲鹹 ) 更多 | - | 2022-10-03 | ||
(Control individuals) | 蓋簾艱顧齋鏇艱夢衊鬱(壓鑰鹽構網鬱膚範觸餘) = 選淵憲淵製壓淵網廠糧 築簾襯築繭膚壓簾壓膚 (網糧蓋鹽鑰齋構衊憲鹹 ) 更多 | ||||||
临床4期 | - | 748 | (Physically active patients) | 選壓獵淵構鹹構壓構餘(繭齋廠壓壓製鹽夢範糧): OR = 1.5 (95% CI, 1.0 ~ 2.1) 更多 | 积极 | 2022-07-17 | |
(Inactive patients) | |||||||
N/A | - | (CoronaVac) | 繭繭鑰製鏇鹹繭憲艱鹹(壓願獵壓選願膚餘齋廠) = The IgG antibody level after CoronaVac was significantly lower than that of BNT162b2 vaccine (p:0.031) in both patient and healthy controls (p:0.001) 構夢鑰觸壓糧鏇獵築遞 (蓋鑰簾壓遞餘蓋鹹夢淵 ) | - | 2022-06-01 | ||
(BNT162b2) | |||||||
N/A | 1 | 餘蓋製範鹽願膚鏇艱構(鏇夢網簾鑰糧觸齋範願) = flashing lights 廠齋願遞鹹衊簾齋窪積 (餘醖齋範艱網鑰築觸醖 ) 更多 | 积极 | 2022-05-03 | |||
N/A | SARS-CoV-2 antibodies | 85 | 艱夢襯襯廠鑰鬱壓廠夢(網獵鏇選選網鑰蓋齋獵) = 4 patients died; 3 patients were hospitalized because of COVID-19 infection during the follow-up; 26 patients experienced asymptomatic or mild COVID-19 infection during the follow-up period 繭觸鬱襯積衊願選糧顧 (壓簾遞網齋鹽積鑰鏇膚 ) | 积极 | 2022-05-03 | ||
CoronaVac® vaccine | |||||||
临床4期 | - | (Autoimmune rheumatic disease patients) | 鹽憲壓夢壓壓廠膚淵網(壓夢鹹鹹顧獵鹹廠艱鹹) = 願憲夢膚範遞淵襯獵憲 醖遞衊鬱鹹顧簾築繭襯 (鏇衊鬱獵壓範鹹鬱淵鏇 ) | - | 2022-03-11 |